Latest news
Rxsight’s Earnings Call: Alcon Deal vs. Headwinds - TipRanksTipRanks · Sun, 09 Aug 2026 00:58:08 GMTWilliam Blair Maintains RxSight(RXST.US) With Hold Rating - MoomooMoomoo · Sat, 08 Aug 2026 11:04:47 GMTCarlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanksTipRanks · Fri, 07 Aug 2026 07:31:36 GMTRxSight: Guidance Withdrawal and Strategy Reset Prompt Travis Steed to Maintain Sell Rating Amid Near-Term Execution Risks - TipRanksTipRanks · Thu, 06 Aug 2026 22:53:41 GMTRyan Zimmerman Reiterates Hold on RxSight Amid Weak Core Trends and Heightened Visibility Risks - TipRanksTipRanks · Thu, 06 Aug 2026 16:53:42 GMTRxSight reports Q2 adjusted EPS (11c), consensus (19c) - TipRanksTipRanks · Wed, 05 Aug 2026 23:57:33 GMT